Consulting and Venture Capital in the life science sector
Joined March 2010
- Tweets 6,591
- Following 0
- Followers 166
- Likes 0
Photos and videos
9 May 2013
Deborah Dunsire exits as Takeda cuts CEO role in Millennium shakeup: Millennium CEO Deborah Dunsire is retirin... bit.ly/1953hjo
9 May 2013
Dunsire Out At Millennium/Takeda, Replaced by Anna Protopapas: Luke Timmerman
Deborah Dunsire, the CEO w... bit.ly/13GA4uo
9 May 2013
Rockwell Medical Set to Disrupt Dialysis With New Drugs, DaVita Deal: Sarah Schmid
In the late 1990s, Wi... bit.ly/10wbihV
9 May 2013
Dendreon Shares Fall Again, as Provenge Sales Slump: Luke Timmerman
Dendreon has made a habit of disappo... bit.ly/193VfXX
9 May 2013
U.S. drug market shrinks for first time: U.S. drug spending dropped last year. While that may be welcome news ... bit.ly/10vpnfx
9 May 2013
The Next Billionaire: A Statistician Who Changed Medicine: Staying up-to-date has never been simpler. Sign up... bit.ly/193CMur
9 May 2013
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More: Bruce V. Bigelow
Amid the hectic pac... bit.ly/15Oaw2H
9 May 2013
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up: Bernadette Tansey
At one edge of the s... bit.ly/1306Ljz
9 May 2013
Biotech Receptos claims $73M IPO prize to fuel oral MS contender: San Diego-based biotech Receptos has priced ... bit.ly/13ERlUQ
9 May 2013
Global CRO Quintiles rakes in $947M as its hot IPO sells at top range: The global CRO Quintiles won some enthu... bit.ly/13E7RnY
9 May 2013
Trevena lands $430M Forest deal, $60M venture round as heart drug heads to PhIIb: bit.ly/13DVsRa
8 May 2013
Inviragen, Global Health Vaccine Maker, Bought by Takeda for $35M: Michael Davidson
Japanese pharmaceuti... bit.ly/13A3Cdh
8 May 2013
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs: Ben Fidler
Nimbus Discovery splashed onto... bit.ly/16ZgnC6
8 May 2013
Big Pharma CEOs Rake in $1.57 Billion in Pay: Staying up-to-date has never been simpler. Sign up for the free... bit.ly/13ziNDy
8 May 2013
Fast-growing Biogen Idec bursts the seams at new Cambridge HQ: When George Scangos took the helm at Biogen Ide... bit.ly/18Ypr6H
8 May 2013
The pharma spin-offs have just begun: After all, investors and shareholders responded strongly to Pfizer's ani... bit.ly/13yQjd6
8 May 2013
Genomics, Biotechnology's Oldest Next Big Thing: The economist Edward Fiedler famously said "He who lives by t... bit.ly/15GpgAy
8 May 2013
Startup biotech charges into PhII with $23M bankroll for rare disease drugs: A little more than a year ago the... bit.ly/18XzqJE
8 May 2013
Lumena Raises $23 Million to Advance Drug for Rare Liver Diseases: Bruce V. Bigelow
San Diego-based Lume... bit.ly/15FjIGx
8 May 2013
Will $28M in Debt Financing Push Good Start Genetics to Big Finish?: Ben Fidler
Six years ago, Good Star... bit.ly/13xoge1